Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. (Q37003956)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2007

Language	Label	Description	Also known as
English	Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.	scientific article published on January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Huntington's disease

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

N A Aziz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

R A C Roos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Reviews in the Neurosciences

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

223-251

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Vasoregulatory activity in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Lipoic acid improves survival in transgenic mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Autonomic nervous system function in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Somatostatin is increased in the basal ganglia in Huntington disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Huntingtin aggregation and toxicity in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Hypocretin-1 (orexin A) levels are normal in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Neuropeptides in neurological disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

The current state of research with peripheral tissues in Huntington disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Membrane fluidity measurements in peripheral cells from Huntington's disease patients

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Brain immunoreactive gonadotropin-releasing hormone in Huntington's chorea and in non-choreic subjects

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Neuropathological changes of the nucleus accumbens in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

The physiology of brain histamine.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

The energetics of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Which factors influence age at onset and rate of progression in Huntington's disease?

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Neuroendocrine function in Huntington's disease: Dopaminergic regulation of prolactin release

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Altered Growth Hormone and Prolactin Responses to Dopaminergic Stimulation in Huntington's Chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Sleep and degenerative neurologic disorders

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Anorexigenic hormones leptin, insulin, and alpha-melanocyte-stimulating hormone directly induce neurotensin (NT) gene expression in novel NT-expressing cell models.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Inhibition of cortisol biosynthesis decreases circulating leptin levels in obese humans

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Essential fatty acids in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Changes in nocturnal sleep in Huntington's and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

An anthropometric assessment of Huntington's disease patients and families

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

White Adipose Tissue: Getting Nervous

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Relationship between CSF hypocretin levels and hypocretin neuronal loss

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Somatostatin: the neuroendocrine story

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Rate and correlates of weight change in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Dysphagia in Huntington's disease: a 16-year retrospective

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Central nervous determination of food storage--a daily switch from conservation to expenditure: implications for the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Demise of a neuronal population in huntington's disease and the importance of hyponeuronogenesis

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Endocrine functions in Huntington's disease. A two-and-a-half years follow-up study

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Studies of hypothalamic function in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Serum dehydroepiandrosterone and cortisol measurements in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Activated immune system in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Exaggerated Growth Hormone Response to Arginine Infusion in Huntington's Disease1

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Growth hormone and prolactin secretion in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Central H1 and H2 receptor participation in the control of water and salt intake in rats.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Cholesterol synthesis in cultured skin fibroblasts from patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Cortical peptide changes in Huntington's disease may be independent of striatal degeneration

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Huntington's disease?growth of fibroblast cultures in lipid-deficient medium: A preliminary report

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Prolactin control in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Characteristics of individuals with Huntington disease in long-term care

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

The biology of pro-thyrotropin-releasing hormone-derived peptides

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Amino acids in the blood in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Huntington's disease and low tryptophan diet

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Plasma-aminoacid levels in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Hypothalamic-endocrine aspects in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Orexin loss in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Growth hormone secretagogues and ghrelin: an update on physiology and clinical relevance

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Sleep and quantitative EEG in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Abnormal Glucose Tolerance and Arginine Tolerance Tests in Huntington’s Disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Increased frequency of diabetes mellitus in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Leptin TRH and ghrelin: influence on energy homeostasis at rest and during exercise

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Impaired phospholipid-related signal transduction in advanced Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Weight changes in Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Chorea-acanthocytosis: Abnormal composition of covalently bound fatty acids of erythrocyte membrane proteins

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Membrane Anomalies in Huntington's Disease Fibroblasts

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Fatty acid patterns and glucose tolerance in Huntington's chorea (author's transl)

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Evidence for progression in frontal cortical pathology in late-stage Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Sympathetic skin response and heart rate variability in patients with Huntington disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Neurobiology of Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Mice lacking melanin-concentrating hormone are hypophagic and lean

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Tryptophan metabolism and oxidative stress in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Gene expression in Huntington's disease skeletal muscle: a potential biomarker

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Fluorescence Studies of Red Blood Cell Membranes from Individuals with Huntington's Disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Evidence for normal fibroblast cell membranes from individuals with Huntington's disease. A fluorescence probe study

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Stimulation of Prolactin and Growth Hormone Secretion by Muscimol, a γ-Aminobutyric Acid Agonist*

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Sleep disturbance and Huntingdon's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Assessment of the nutrition status of patients with Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Neurotensin: peptide for the next millennium

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Immunohistochemical mapping of neurophysins and calcitonin gene-related peptide in the human brainstem and cervical spinal cord

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Increased melanin concentrating hormone receptor type I in the human hypothalamic infundibular nucleus in cachexia

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

A randomised, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Body weight is modulated by levels of full-length huntingtin

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Stable vasopressin innervation in the degenerating human locus coeruleus in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Analytical methods for evaluating episodic secretory activity within neuroendocrine axes

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Nocturnal sleep in huntington's disease

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

To eat or to sleep? Orexin in the regulation of feeding and wakefulness

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Role of hypothalamic interleukin-1beta (IL-1beta) in regulation of energy homeostasis by melanocortins

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Melanocortin signaling and anorexia in chronic disease states

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Cerebrospinal fluid norepinephrine reductions in man after degeneration and electrical stimulation of the caudate nucleus

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Appetite control

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2007.18.3-4.223

21 January 2018

Identifiers

10.1515/REVNEURO.2007.18.3-4.223

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18019608%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37003956&oldid=2097811420"